HUAOTA BIOPHARM
Shanghai Huaota Biopharm is a wholly owned subsidiary of Huahai Pharmaceuticals and was established in September 2013. Huaota is dedicated to develop high quality biological drugs for global market to meet the demand of availability and affordability for high-end biological products from global patients. Huaota employs the state-of-the-art biopharmaceutical manufacturing technology and equipments to build production line meeting the GMP requirement from CFDA, US FDA and EU EMA. Huaota currently has one 200L and one 1000L disposable bioreactor and two fill-and-finish lines to support both prefilled syringe and vial filling.
HUAOTA BIOPHARM
Industry:
Biopharma Biotechnology Health Care Manufacturing Medical
Founded:
2013-09-10
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.huaota.com
Total Employee:
251+
Status:
Active
Contact:
86-021-51320756
Email Addresses:
[email protected]
Total Funding:
3 M CNY
Technology used in webpage:
Euro Pound Sterling Japanese Yen China Telecom Amap
Current Employees Featured
Investors List
Huahai Yaoye
Huahai Yaoye investment in Angel Round - Huaota Biopharm
Official Site Inspections
http://www.huaota.com
- Host name: 112.64.166.220.broad.dy.sc.dynamic.163data.com.cn
- IP address: 220.166.64.112
- Location: China
- Latitude: 30.6667
- Longitude: 104.0667
- Timezone: Asia/Shanghai
More informations about "Huaota Biopharm"
上海华奥泰生物药业股份有限公司 - huaota.com
简介Shanghai Huaota Biopharmaceutical Co., Ltd. (aka ‘Huaota’) was established in September 2013. Huaota is a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd. Driven by innovation …See details»
huaota.com - 上海华奥泰生物药业股份有限公司
简介上海华奥泰生物药业股份有限公司（以下简称 “华奥泰”）成立于2013年9月，为浙江华海药业股份有限公司（股票代码：600521）的子公司，注册资金3亿元，累计投资7亿元。公司已被 …See details»
上海华奥泰生物药业股份有限公司-关于我们 - huaota.com
自成立以来，华奥泰持续专注于创新与发展，已建成完善的一体化生物新药研发平台和体系，包括单抗、双抗、融合蛋白及ADC等药物研发平台和符合GMP标准的原液和制剂中试平台。华奥 …See details»
Huaota Biopharma - Huabo Bio
Profile Huaota Biopharma is a clinical stage biotechnology company with a focus on discovery, development and commercialization of biologic cancer and autoimmune therapeutics. …See details»
Huaota Biopharm - Crunchbase Company Profile
Huaota is dedicated to develop high quality biological drugs for global …See details»
Huaota Biopharm - Financial Details - Crunchbase
Huaota Biopharm develops high-quality biological drugs for the global market.See details»
Huaota Biopharm - LinkedIn
Huaota Biopharm | 12 followers on LinkedIn. Huaota Biopharmaceutical is a global biopharmaceutical research and development company primarily …See details»
Huabo Biopharm (Shanghai) Co., Ltd.
Huabo Biopharm Co., Ltd., (aka ‘Huabo Biopharm’), established in June 2011, is a subsidiary of Shanghai Huaota Pharmaceutical Co., Ltd. At …See details»
Shanghai Huaaotai Biopharmaceutical Co., Ltd.
4 days ago 了解Shanghai Huaaotai Biopharmaceutical Co., Ltd. (上海华奥泰生物药业股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的45项临床试验, 197篇新闻和9篇文 …See details»
华博生物医药技术（上海）有限公司
公司风采 人才招聘 联系我们 联系方式 留言反馈 药物警戒部门联系方式： 公共联系电话：150 2649 8629 药物警戒邮箱：[email protected] 华 …See details»
Huaota Biopharm - Profiles & Contacts - Crunchbase
Huaota Biopharm develops high-quality biological drugs for the global market.See details»
Huaota Biopharm Revenue, Funding, Alternatives & Headcount
Huaota Biopharm - Free Access to Funding, Revenue, Investors, Headcount Trends, Alternatives, Similar Companies, Competitors & Sr. Management data.See details»
Shanghai Huaota Biopharm - VentureRadar
Shanghai Huaota Biopharmaceutical Co., Ltd. is a pioneering company in the biopharmaceutical industry, specializing in the development of innovative antibody therapies. The company's …See details»
Huaaotai Biopharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Huaaotai Biopharma. Use the PitchBook Platform to explore the full profile.See details»
Shanghai Huaaotai Biopharmaceutical Co., Ltd. - Patsnap
4 days ago Explore Shanghai Huaaotai Biopharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 45 clinical trials, 2 news, and 9 literature, Disease …See details»
Dual blockade of IL-17A and IL-36 pathways via a bispecific …
The authors declare that this study received funding from Huaota Biopharmaceutical Co. Ltd. The funder had the following involvement in the study: study design, collection, analysis, …See details»
上海华奥泰生物药业股份有限公司-关于我们 - huaota.com
Over the years, Huaota has completed many science and technology projects in collaboration with universities, research institutes, and other research organizations in China and globally. In …See details»
【融资】华奥泰生物（Huaota）完成2亿元融资医药新闻-ByDrug
Dec 26, 2024 华奥泰生物 （ Huaota ）近日宣布完成2亿元融资，投资方海璟创投。 上海华奥泰生物药业股份有限公司（华奥泰生物，Huaota）成立于2013年9月，为浙江华海药业股份有限 …See details»
Zhejiang Huahai Pharmaceutical’s Subsidiary Huaota Bio Secures …
Dec 26, 2024 Huaota Bio’s Product Pipeline and Future Prospects Since its inception in 2013, Huaota Bio has established a rich product pipeline that includes monoclonal antibodies, …See details»
Orphanet: SHANGHAI HUAOTA BIOPHARMACEUTICAL CO., LTD.
Shanghai Huaota Biopharmaceutical Co., Ltd. Shanghai Huaota Biopharmaceutical Co., Ltd. No.538 Cailun Road, Zhangjiang High-tech. Park 201203 SHANGHAI CHINASee details»